Stargazing at Digital Pharma East
I am really looking forward to the 4th Annual Digital Pharma East coming up on October 18th in Philadelphia. In addition to presenting, I plan to do some major stargazing while I am there. I don’t mean ‘star’ in the manner of the cult of celebrity. I am defining stars as people who have something really valuable and/or interesting to say. It feels a little mercenary to go with the express intent of cherry picking knowledge from experts given the themes around sharing – but I guess that’s just part of the allure.
I’m also very much looking forward to reconnecting with Berci Mesko (@Berci) who I have not seen in a couple years, talking shop with social media flag bearer Bryan Vartabedian (@Doctor_V) who will likely be pressed for time from Co-chairing the event, having a face-to-face chat with Phil Baumann (@PhilBaumann) whose mind works unlike any other I’ve encountered in this space, meeting Gilles Frydman (@gfry) who is the final piece of the ePatient trinity, as well as Shwen Gwee (@shwen) who has both tweet cred and does great work.
In addition to those folks, I may be most eager to see presentations by representatives from Comscore and Within3, along with Cluetrain Manifesto author Doc Searls and futurist Ian Morrison. Needless to say, I am planning to see every single presentation on the final day, which is dedicated to mobile/mHealth. The rest of the time, it’s just a question of which Stream. Finally, I am curious to see how the unconference activities and #SocPharm sessions play out relative to previous HealthCamp events I’ve seen.
As for me, I’ll be presenting “Social Media Research: Partnering with Academia”. The link to the slides on the Digital Pharma conference site will be provided here after the presentation and will be available beyond that at SlideShare as per. I’m curious to see the reception given that the composition of the audience is pretty different than who I have been interacting with recently. I definitely have a (relatively) longstanding interest in the subject as one of the first articles we published on the topic was “Legal and regulatory risk associated with Web 2.0 adoption by pharmaceutical companies” in the Journal of Medical Marketing. We’ve also published several other studies on interactions between different healthcare professionals and representatives from Pharma. Ultimately, I am banking on the fact that I actually do what I will be talking about and have some concrete takeaways for those interested in the topic. I’m also optimistic that using an audience response system and building in time for discussion will help make it legitimately interactive. We shall see.
Overall, I am looking forward to reconnecting and making new connections, planting the seeds for future research collaborations, and learning from area experts that are rarely available in this concentration. I hope to see you there, hear your thoughts, or cross paths via #DigPharm (or whatever the hashtag ends up being)!
- Uber brings on-demand flu shots to Boston, NYC and DC for a day engadget.com/2014/10/23/ube… 3 hours ago
- RT @jenni_whalen: My favorite @MedTechBoston story this week is all about #Myo, #GoogleGlass and #wearables in healthcare: https://t.co/CL8… 3 days ago
- How will wearable technology change the future of healthcare by @philipshealth feat @lucienengelen & @ePatientDave bit.ly/1Cw3Dhq 5 days ago
- Move over Jack Handey RT @Doctor_V: Nice insight .. Killer Apps in the Gigabit Age | From @pewinternet bit.ly/1wirMbt 1 week ago
- #mHealth and Apps: Framework to Assess Risk and Promote Safer Use [JMIR] by @thomasllewis bit.ly/1wMtQdj h/t @alabriqu 1 week ago